UnfairGaps
🇧🇷Brazil

Risk of Counterfeit and Unauthorized Medical Materiel Entering Military Supply Chains

1 verified sources

Definition

DoD medical materiel management policy explicitly lists counterfeit materiel and unauthorized supply chain activities as key risks that must be monitored and mitigated in the medical supply chain, indicating prior or ongoing attempts to inject non‑authentic or unapproved products. Even when detected before patient use, investigation, quarantine, and replacement of suspect product impose recurring costs.

Key Findings

  • Financial Impact: Low millions of dollars over multi‑year periods across DoD due to investigations, write‑offs of suspect stock, and premium sourcing to replace compromised items (signalized by the creation of dedicated supply chain risk management programs and controls).
  • Frequency: Monthly
  • Root Cause: Globalized sourcing, emergency procurement during crises, and use of multiple intermediaries heighten vulnerability to counterfeit or unauthorized suppliers; inconsistent vetting and monitoring practices further increase exposure, necessitating costly risk management and remediation.

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Armed Forces.

Affected Stakeholders

DLA medical contracting and procurement officers, Supply chain risk management teams, Depot and warehouse managers, Investigators and auditors within DoD logistics and law enforcement, Clinical staff when products must be withdrawn or replaced

Action Plan

Run AI-powered research on this problem. Each action generates a detailed report with sources.

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Related Business Risks

Operational Capacity Loss from Inefficient Medical Logistics and Delayed Deliveries

Lost productivity and mission impact equivalent to several million dollars per year across the enterprise when surgeries or treatments are delayed and personnel are underutilized due to missing supplies (queueing and optimization research on military medical logistics is funded precisely because these inefficiencies are material).

Waste from Medical Product Expiry and Environmental Exposure in Deployed Supply Chains

Estimable at hundreds of thousands to low millions of dollars per year across large deployments due to expired or temperature‑compromised medicines that must be written off (NATO documents treat this as a recurring risk that must be mitigated with quality systems and controls).

Poor Sourcing and Inventory Decisions from Limited End‑to‑End Visibility

Several million dollars per year in avoidable spend and opportunity cost across the DoD medical supply chain, inferred from the scale of optimization initiatives and system‑modernization investments aimed at correcting prior inefficiencies.

Cost of Poor Quality from Substandard or Degraded Medical Products in Military Operations

Recurring losses in the hundreds of thousands of dollars per year across major operations due to product recalls, destruction of compromised stock, and duplicated treatment or diagnostic procedures (precise aggregate figures are not publicly broken out but are material enough to justify detailed quality management frameworks).

Excess Medical Inventory and Buffer Stock in Military Treatment Facilities

Several million dollars per year across the DLA medical supply chain and Army medical treatment facilities due to over‑stock, obsolescence, and expiry (exact enterprise dollar figure not disclosed, but stock-keeping units were cut from ~1,600 to 1,100 to reduce carrying costs, indicating large recurring savings and corresponding prior losses).

Regulatory and Policy Non‑Compliance Risk in Military Medical Distribution

Typically in the hundreds of thousands of dollars per year across large commands for remediation projects, additional inspections, training, and system upgrades triggered by audit and compliance findings in medical supply operations.